Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003201 |
---|---|
Receipt number | R000003870 |
Scientific Title | A phase II study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma |
Date of disclosure of the study information | 2010/02/17 |
Last modified on | 2019/09/04 15:15:45 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/02/17 12:53:09 | ||
2 | Update | 2011/02/21 17:52:54 | Name of person sending information Organization Division name Address |
|
3 | Update | 2012/02/17 15:53:59 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2012/03/28 07:30:53 | Email |
|
5 | Update | 2015/02/20 12:38:32 | TEL Last name of contact person Last name of contact person TEL |
|
6 | Update | 2016/08/23 19:31:12 | Name of primary person or sponsor Organization |
|
7 | Update | 2016/09/23 13:58:09 | Recruitment status |
|
8 | Update | 2017/08/26 12:19:55 | Last follow-up date Date of closure to data entry Date trial data considered complete |
|
9 | Update | 2019/09/04 14:49:50 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Organization Organization Zip code Address Name of person sending information Organization Organization Address Address Tel |
|
10 | Update | 2019/09/04 14:57:24 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
11 | Update | 2019/09/04 15:15:45 | Recruitment status Date of IRB |